Jeffrey Scott Riley
Director · Gain Therapeutics, Inc.
Individual
- 2026
- Jul 17, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Jeffrey Scott Riley's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- HRTG GPE, LLC - $50.00M in KARD purchases and sales in the last 12 months
- Redmile Group, LLC - $49.64M in ADCT purchases and sales in the last 12 months
- Gary S. Guthart - $48.79M in ISRG purchases and sales in the last 12 months
- Robert B. Ford - $48.22M in ABT purchases and sales in the last 12 months
- Roger Adsett - $47.51M in INSM purchases and sales in the last 12 months
- Brian Taylor Slingsby - $46.36M in MLYS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey Scott Riley?
Jeffrey Scott Riley is a corporate insider, tracked as Director of Gain Therapeutics, Inc. (GANX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeffrey Scott Riley submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.